EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 53 filers reported holding EDGE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $21,000 | -86.8% | 17,552 | +3.7% | 0.00% | – |
| Q4 2017 | $159,000 | -27.1% | 16,932 | -16.5% | 0.00% | – |
| Q3 2017 | $218,000 | +6.3% | 20,285 | +1.6% | 0.00% | – |
| Q2 2017 | $205,000 | +34.0% | 19,960 | +19.1% | 0.00% | – |
| Q1 2017 | $153,000 | -23.5% | 16,765 | +4.8% | 0.00% | -100.0% |
| Q4 2016 | $200,000 | +28.2% | 16,001 | +7.0% | 0.00% | – |
| Q3 2016 | $156,000 | +16.4% | 14,950 | +12.8% | 0.00% | – |
| Q2 2016 | $134,000 | – | 13,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |